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Edited by Lukas HuberAbstract Loss of mitochondrial membrane potential (DWm) and
release of AIF (apoptosis-inducing factor) from mitochondria are
key steps in apoptosis. In TF-1 model, DWm was depolarized with
AIF release during erythroid development. Yet, no DNA frag-
mentation was observed. When DWm depolarization had been
blocked, erythropoiesis was suppressed. Interestingly, heat shock
protein 70 (Hsp70) was found transiently upregulated during
depolarization and it retained AIF in the cytosol to avoid
DNA damages. When Hsp inhibitor was added, DNA fragmen-
tation occurred. We show this mechanism for the ﬁrst time in
erythropoiesis how cells with DWm depolarization and AIF re-
lease escape apoptosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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701. Introduction
Activation of caspase-3 is a key step in apoptosis leading to
DNA fragmentation in most cell types. However, recent work
suggests that activation of caspase-3 does not always condemn
cells to die but sometimes plays an important role in some
other cellular processes such as cell diﬀerentiation [1]. For
example, activation of caspase-3 did not lead to apoptotic
DNA fragmentation in erythroid cells and application of
inhibitor or small interfering RNA into early erythroid cells
against caspase-3 impaired their maturation [2–4]. Up till
now, the mechanism for the activation of caspase-3 during
erythropoiesis is not fully understood.Abbreviations: AIF, apoptosis-inducing factor; CAD, caspase-acti-
vated DNase; CCCP, carbonyl cyanide m-chlorophenylhydrazone;
CyA, cyclosporin A; EPO, erythropoietin; GM-CSF, granulocyte-m-
acrophage colony stimulating factor; Hsp70, heat shock protein 70;
ICAD, inhibitor of CAD; JC-1, 5,50,6,60-tetrachloro-1,1 0,3,3 0-tetra-
ethylbenzimidazolcarbocyanine iodide; KNK437, N-formyl-3,4-meth-
ylenedioxy-benzylidene-gamma-butyrolactam; MAb, monoclonal
antibody; STS, staurosporine; TMRM, tetramethylrhodamine methyl
ester; TdT, terminal deoxynucleotide transferase; TUNEL, terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling; DWm,
mitochondrial membrane potential
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doi:10.1016/j.febslet.2006.11.082During normal erythropoiesis, non-lethal caspase-3 activa-
tion is usually associated with mitochondrial depolarization
[4]. Nonetheless, the molecular basis of how erythroblasts re-
mained viable after DWm depolarization is not clear. As in nor-
mal cases, the loss of DWm accompanies the release of
cytochrome c and apoptosis-inducing factor (AIF) into the
cytosol, which respectively triggers caspase-dependent and
-independent DNA fragmentation [5,6]. If there is really a need
for activating caspase-3 through the mitochondrial apoptotic
pathway during erythroid development, it would be equally
important to avoid the disastrous cell death execution medi-
ated by cytochrome c and AIF.
Recently, we have established an in vitro erythropoiesis model
using TF-1 cells, and illustrated the signiﬁcance of caspase-3
activation and a downstream protective mechanism by reducing
caspase-dependent DNase (CAD) at the mRNA and protein
level during the erythropoiesis [7]. With these observations,
we hypothesized that mitochondrial depolarization should be
an upstream event for the activation of caspase-3 during ery-
throid development. If this hypothesis is correct, a protective
mechanism should exist to block the AIF-mediated DNA deg-
radation. In the present study, we conﬁrmed in TF-1 cells that
DWm depolarization played an important role in the erythroid
development. However, release of AIF was only transiently ob-
served, and the DWm was subsequently restored. Moreover, the
release of AIF did not lead to any large-scale or nucleosomal
DNA fragmentation. Notably, we demonstrated here for the
ﬁrst time that heat shock protein 70 (Hsp70) antagonized the
translocation of AIF into the nucleus to avoid DNA fragmen-
tation during erythroid diﬀerentiation.2. Materials and methods
2.1. Chemicals and reagents
Recombinant human erythropoietin (EPO) was purchased from
Roche. Granulocyte-macrophage colony stimulating factor (GM-
CSF) and cyclosporin A (CyA) were obtained from Sigma. Acridine
orange (AO), TMRM (tetramethylrhodamine methyl ester) and
JC-1 (5,5 0,6,6 0-tetrachloro-1,1 0,3,3 0-tetraethylbenzimidazolcarbocya-
nine iodide) were acquired from Molecular Probes. Heat shock protein
inhibitor, N-formyl-3,4-methylenedioxy-benzylidene-gamma-butyro-
lactam (KNK437) was purchased from Calbiochem.
2.2. Cell culture and diﬀerentiation induction
Human cell line TF-1 was purchased from American Type Culture
Collection (ATCC). Cells were maintained at 37 C, 5% CO2 in RPMI
1640 medium (Gibco) supplemented with 10% (v/v) fetal bovine serum,
1% (v/v) penicillin–streptomycin, 1 mM sodium pyruvate, 4.5 g/lblished by Elsevier B.V. All rights reserved.
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tions. Prior to induction of diﬀerentiation, cells were kept in a medium
with FBS overnight, followed by the addition of EPO (1 U/ml) on the
next day. Renewal of medium and EPO (1 U/ml) were done on alter-
native days and the cell density was maintained at 4 · 105 cells/ml).2.3. Assays for cell diﬀerentiation
Cell diﬀerentiation was evaluated by staining of erythroid lineage
marker CD71 with mouse anti-CD71 monoclonal antibody (MAb)
(Pharmingen) and FITC-conjugated goat anti-mouse antibody
(Merck). Fluorescence signals were detected and analyzed using ﬂow
cytometry (Becton Dickinson, FacSort).2.4. Assay for mitochondrial membrane (DWm) depolarization
DWm was determined by using TMRM or JC-1. When the DWm is
low, there is very little accumulation of JC-1 in the cells and the dye
at low concentration exists as a monomer that emits green ﬂuores-
cence. When the DWm is high, more JC-1 is accumulated and the dye
at high concentration forms aggregates which cause a shift in the ﬂuo-
rescence emission from green to red. Thus, the emission of JC-1 can be
used as a sensitive measure of DWm. For the TMRM, the dyes are read-
ily sequestered by polarized mitochondria. The dye will be washed out
of the cells once the DWm is lost. In our experiments, cells (0.5 · 106)
were washed with phosphate-buﬀered saline (PBS) twice and stained
with 0.5 ml serum-free RPMI containing TMRM (1 lM) or JC-1
(10 lM) at 37 C, 5% CO2 for 15 min. Cells were then subject to ﬂow
cytometric analysis (Becton Dickinson, FacSort). For the positive con-
trol, cells were incubated with mitochondrial uncoupler carbonyl cya-
nide m-chlorophenylhydrazone (CCCP, 50 lM) for 15 min, which
causes a collapse of DWm.
2.5. Detection of DNA fragmentation by agarose electrophoresis
Internucleosomal DNA fragmentation was observed in agarose gel
electrophoresis. Cells (1 · 106) were lysed with lysis buﬀer (5 mM Tris,
100 mM EDTA and 1% (w/v) SDS) and proteinase K (200 lg) at 37 C
overnight. DNA was then puriﬁed by phenol–chloroform extraction
and precipitated by absolute ethanol at 70 C. DNA was then dis-
solved in TE buﬀer for quantiﬁcation at O.D. 260 nm. Five lg of
DNA was resolved in 1.5% agarose gel electrophoresis and visualized
after staining the DNA with ethidium bromide. For large size DNA
fragmentation, 1 · 106 cells were resuspended in 20 ll of 1% (w/v)
low melting agarose. The mixture was then directly loaded into the
wells of 1% (w/v) agarose gel with 1% (w/v) SDS and 200 lg proteinase
K to allow solidiﬁcation. The gel was subsequently resolved with elec-
trophoresis and stained with ethidium bromide to visualize DNA
bands.2.6. Detection of DNA fragmentation by TUNEL assay
DNA fragmentation was investigated by in situ cell death detection
kit (Roche) using terminal deoxynucleotide transferase (TdT)-medi-
ated dUTP nick-end labeling (TUNEL) technique. Brieﬂy, 2 · 106 cells
were washed with PBS and ﬁxed with 2% paraformaldehyde for 1 h,
followed by permeabilization with 0.1% Triton X-100 and 0.1% so-
dium citrate on ice for 2 min. Thereafter, cells were incubated in a mix-
ture of TdT and ﬂuorescein-incorporated nucleotides at 37 C for 1 h,
and the labeled cells were then examined by ﬂow cytometry.
2.7. Western blotting
For total protein lysate preparation, cells were lysed in 1% (w/v)
SDS, 1 mM Na3VO4, 10 mM Tris, 5 mM MgCl2 with protease inhibi-
tors 21 lg/ml aprotinin, 5 lg/ml leupeptin and 1 mM PMSF at pH 7.4
for 1 h at room temperature. Samples were then boiled for 10 min and
then centrifuged at 14000 rpm at 4 C. Subsequently, 25 lg of protein
extracts was analyzed by 12% SDS–PAGE and blotted to PVDF (poly-
vinylidene ﬂuoride) membrane. Study of mitochondrial protein release
was performed using selective digitonin lysis method as described [7].
Brieﬂy, 4 ·106 cells were resuspended with 50 ll of lysis buﬀer
(75 mM NaCl, 1 mM NaH2PO4, 8 mM Na2HPO4, 250 mM sucrose,
21 lg/ml aprotinin, 5 lg/ml leupeptin, 1 mM PMSF and 0.8 lg/ll dig-
itonin) and vortexed for 30 s. The mixture was centrifuged at
14000 rpm for 1 min and the supernatant collected was the cytosolic
fraction. The pellet was then resuspended again in 50 ll of lysis buﬀer
(same as above, except with 8 lg/ll digitonin), vortexed and centri-fuged to collect the supernatant, which represented the mitochondrial
fraction. Ten ll of cytosolic or mitochondrial fractions was using for
12% SDS–PAGE and Western blotting analysis. Membranes were
incubated with rabbit polyclonal anti-human caspase-9 antibody
(Ab) (Santa Cruz), mouse anti-human cytochrome c MAb (Pharmin-
gen), mouse anti-human AIF MAb (Santa Cruz), rabbit polyclonal
anti-human Hsp70 Ab (Stressgene), mouse anti-human b-actin MAb
(Santa Cruz) or mouse anti-human b-tubulin MAb (Boehringer). After
washing, the membranes were incubated with horseradish peroxidase-
conjugated secondary Ab (Santa Cruz) and developed with ECL re-
agent (Amersham).
2.8. Immunocytochemistry
Cells were seeded on polylysine-coated glass slides for 15 min. After
adhesion, cells were ﬁxed with 1% formaldehyde (Sigma) for 15 min at
room temperature, and then permeabilized with 1% Triton X-100 for
5 min at 4 C, and blocked with 3% (w/v) BSA in PBS before incuba-
tion with antibody at appropriate dilutions. Cells were stained with
rabbit polyclonal anti-human Hsp70 Ab (Stressgene) or mouse anti-
human AIF MAb (Santa Cruz) followed by FITC- or PE-conjugated
secondary Ab (Merck). Cells were then observed under confocal
microscope after washing the cells 3 times with 0.2% Triton X-100 in
PBS. Confocal images of cells were acquired with a confocal laser-
scanning microscope (Multiprobe 2001, Molecular Dynamics) ﬁtted
with an argon laser (488 nm for excitation). For ﬂuorescence determi-
nation, a long pass emission ﬁlter of 575 nm for detecting PE signals
and a band pass ﬁlter of 540 nm for FITC were used. At the end of
experiment, the voltage of photomultiplier detector was lowered until
no FITC or PE signal was detected. AO (ﬁnal concentration 0.1 lg/ml)
was then added to locate the position of cell nucleus. Images and ﬂuo-
rescence intensities were processed by software ImageSpace 3.2.
2.9. Co-immunoprecipitation
TF-1 cells (4 · 106) after diﬀerent treatments were harvested, washed
in PBS and then lysed in 0.5% (v/v) Nonidet P-40, 0.2 mM Na3VO4,
50 mM Tris–Cl, 120 mM NaCl with protease inhibitors 10 lg/ml apro-
tinin, 5 lg/ml leupeptin and 1 mM PMSF at pH 7.4 for 15 min at 4 C.
After removing the debris by centrifugation for 15 min, 10 lg of rabbit
polyclonal anti-human AIF Ab (Santa Cruz) was added to the lysates.
The mixture was rocked at 4 C for 1 h and then with protein A–Se-
pharose slurry for another hour. Subsequently, the Sepharose was
washed for 5 times with PBS for 15 min each. When washing was com-
pleted, proteins in the Sepharose slurry were analyzed by standard
SDS–PAGE and Western blotting with mouse anti-human AIF
MAb (Santa Cruz) and rabbit polyclonal anti-human Hsp70 antibody.3. Results
3.1. Mitochondrial depolarization played a critical role in
erythroid diﬀerentiation
TF-1 cells become committed to erythroid diﬀerentiation
after EPO treatment [7]. The change in DWm during EPO-in-
duced TF-1 diﬀerentiation was studied by using ﬂow cytome-
try and JC-1. For positive controls, cells were treated with
protonophore CCCP and the DWm was dissipated as indicated
by an increase in the number of cells with high JC-1 green ﬂuo-
rescence (Fig. 1 middle panel). Cells in the R1 region were
therefore the cell population with collapsed DWm.
As shown in the upper panel of Fig. 1, there was an abrupt
drop in DWm at day 6 after EPO treatment (R1: 69.3% at day 6
versus 11.8% at day 4). The drop in DWm was sustained for 4
days (R1 at day 8: 53.5%, day 10: 31.5%) and the DWm was
then gradually returned back to normal (R1 at day 12:
17.1%). During this diﬀerentiation process, no dead cells were
detected (see later). At the end of each experiment, the cells
were challenged with CCCP and it can be seen that all the cells
were sensitive to CCCP and became depolarized (Fig. 1 middle
panel).
Fig. 1. Mitochondrial membrane potential was depolarized in TF-1 cells during EPO treatment. TF-1 cells (4 · 105 ml1) were cultured with EPO
(1 U/ml) for diﬀerent days in the presence or absence of cyclosporin A (CyA) (1 lM) for 24 h at 37 C, 5% CO2. The mitochondrial membrane
potential (DWm) was then determined by using ﬂow cytometry with JC-1 (10 lM). At the end of experiments, CCCP (50 lM) was added to depolarize
DWm. Figure on the top of region R1 represents the % of cells with depolarized DWm.
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of the mitochondrial permeability transition, 1 lM), the drop
in DWm was reduced throughout the erythroid development
process (Fig. 1 lower panel). Still, more cells with a depolarized
DWm were found at day 6 to day 10. Taken together, our re-
sults suggest that the changes in DWm in response to EPO at
diﬀerent days were physiological. Remarkably, the timing of
DWm depolarization was in coherence with our previous ﬁnd-
ing that caspase-3 was activated at day 6 after EPO treatment
[7]. These observations strongly suggest a close relationship be-
tween the two events at day 6 after EPO treatment.Fig. 2. Cyclosporin A blocked the expression of CD71 in the EPO-treated TF
presence or absence of cyclosporin A (1 lM) for diﬀerent days at 37 C, 5% CO
in each determination represents the % of cells expressing CD71 in the selecNext, we asked whether the drop in DWm is important in the
erythroid development. To address this question, we used CyA
again to block the DWm depolarization and the antibody
against erythroid marker CD71 to check for the degree of
erythropoiesis. It was found that, in the absence of CyA, the
percentage of cell population with CD71 expression increased
in a time dependent manner after EPO treatment (Fig. 2 upper
panel). In the presence of CyA (1 lM), the expression of CD71
was blocked and the blockage was more pronounced in the
groups with 6 days or longer EPO treatment (Fig. 2 lower
panel).-1 cells. TF-1 cells (4 · 105 ml1) were treated with EPO (1 U/ml) in the
2. Expression of CD71 was then determined by ﬂow cytometry. Figure
ted region.
Fig. 3. Mitochondrial membrane potential was depolarized in TF-1 cells during erythropoiesis.TF-1 cells (4 · 105 ml1) were cultured with EPO
(1 U/ml) for diﬀerent days at 37 C, 5% CO2. For the positive control, cells were treated with staurosporine A at the concentration as indicated for
24 h at 37 C, 5% CO2. The mitochondrial membrane potential and expression of CD71 were determined, respectively, by using TMRM (1 lM) and
anti-CD71 antibody with ﬂow cytometry. Figures at the corners represent the % of cells in the corresponding quadrants.
Fig. 4. Change of cytochrome c, AIF and caspase-9 in TF-1 cells after
EPO treatment. TF-1 cells (4 · 105 ml1) were cultured with EPO (1 U/
ml) for diﬀerent days at 37 C, 5% CO2. After selective cell permeabi-
lization with digitonin, proteins in the cytosol were isolated. Total cell
lysates or cytosolic proteins containing equal amount of proteins per
lane were subject to standard SDS–PAGE and Western analysis with
antibodies for cytochrome c (11 kDa), AIF (57 kDa), procaspase-9
(46 kDa), active caspase-9 (10 kDa), b-actin (43 kDa, as an internal
control for cytosolic proteins) and b-tubulin (55 kDa, as an internal
control for total lysates).
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and the anti-CD71 antibody for the erythroid marker CD71
simultaneously. It was found in the two-variant ﬂow cytomet-
ric analysis that the cell population with decreased DWm
showed a time-dependent increase in the expression of CD71
(upper left quadrant: 8.5% at day 4 to 36.1% at day 8)
(Fig. 3). On the other hand, no signiﬁcant CD71 expression
was found in the cells with depolarized DWm after treatment
with staurosporine (STS, a potent apoptosis inducer), even at
sub-lethal doses (Fig. 3 lower panel), suggesting that CD71
expression is not a concomitant event with the collapse of
DWm. Detailed examination of the EPO-treated groups in
Fig. 3 showed that the peak of TMRM ﬂuorescence in the
CD71 positive cells shifted back to the right-hand side and
the percentage of cell population in the upper right quadrant
also increased in a time-dependent manner (day 4: 5.6%; day
6:11.1% and day 8: 24.3%) implying a recovery in the DWm.
This observation explains why the percentage of CD71 positive
population increased steadily (Fig. 2) while the DWm showed a
biphasic change with a drop peaked at day 6 (Fig. 1). Taken
together, our results indicate that DWm depolarization played
a critical role in erythroid diﬀerentiation and the depolarized
DWm recovered along the erythroid diﬀerentiation.
3.2. Cytochrome c and AIF are released from mitochondria of
the EPO-treated cells
Western blot analysis was performed to determine if there
were any releases of cytochrome c and AIF from the mito-
chondria coupling to the drop of DWm during TF-1 diﬀerenti-
ation. As illustrated in Fig. 4, cytochrome c was noticeably
released into the cytoplasm predominantly at day 6 after
EPO treatment, with a concomitant decrease of cytochrome
c in the mitochondrial portion. Similar observation was foundin AIF except that the amount of mitochondrial AIF did not
change much. Such observation matched well with our ﬁnding
in the JC-1 assay (Fig. 1). The release of mitochondrial pro-
teins was further conﬁrmed by measuring the cleavage of pro-
caspase-9, one of the eﬀector caspases which is activated by
cytochrome c, Apaf-1 and dATP [8,9]. Our immunoblot assess-
ment revealed a decrease in procaspase-9 with a corresponding
increase in its active form p10 commencing from day 6 after
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chrome c and AIF were released from mitochondria and eﬀec-
tor caspases are activated.
3.3. DNA fragmentation was not observed despite release of AIF
Our pervious work has indicated that downregulation of
CAD is a protective mechanism to prevent cells from dying in
spite of the activation of caspase-3 during erythroid develop-
ment [7]. However, liberation of AIF from mitochondria to
the cytoplasm remained a problem to the cells for its ability
to induce large-scale (50 kbp) DNA fragmentation in a cas-
pase-independent manner after entering the nucleus [10]. In
the light of this, we investigated whether high molecular weight
and internucleosomal (with multiples of 200 bp) DNA frag-
mentation occurred in TF-1 cells at day 6 after EPO treatment.
As shown in Fig. 5, neither DNA laddering nor high molecular
weight DNA fragmentation was detected in the TF-1 cells be-
fore and after incubation with EPO. On the other hand, cells
treated with STS showed both the large scale and internucleos-
omal DNA fragmentation (Fig. 5). These observations are con-
sistent with our previous study that no DNA damage was
found in the EPO-treated TF-1 by using TUNEL assay [7].
3.4. Upregulation of Hsp70 caused cytosolic retention of AIF
Hsp70 is known to be a molecular chaperone to help refold-
ing of proteins during heat stress situations [11]. Hsp70 also
prevents apoptosis. One of the mechanisms by which Hsp70
intervenes apoptosis is to antagonize AIF released from the
mitochondria, and to retain AIF in the cytoplasm [12–16].
To further address the inability of AIF to trigger DNA frag-
mentation during TF-1 diﬀerentiation, the expression of Hsp70
was investigated. As illustrated in Western blot analysis, the
Hsp70 expression was transiently increased at day 6 after
EPO treatment (Fig. 6A). In order to conﬁrm the interaction
of Hsp70 with AIF, co-localization of the two proteins inFig. 5. Assessment of large scale and oligonucleosomal DNA fragmentatio
cultured with EPO (1 U/ml) for diﬀerent days or staurosporine (STS) at the c
DNA was puriﬁed from 1 · 106 cells. Large scale (left panel) and oligonucl
agarose electrophoresis.TF-1 cells was assayed by using confocal microscopy and
immunocytochemistry. In Fig. 6B, cells after treatments were
ﬁxed and labeled with anti-AIF, anti-Hsp70 antibodies, and
AO to locate the position of cell nucleus at the end of
experiment. In the control TF-1 cells (Fig. 6B, ﬁrst row),
AIF appeared punctuate, as expected for their mitochondrial
localization, and the Hsp70 signals were weak. After STS
treatment, Hsp70 signals were weak also while AIF exhibited
a uniform cellular distribution in both the cytosol and nucleus
(Fig. 6B, second row), suggesting that AIF was translocated
into the nucleus after STS treatment. In the EPO-treated TF-
1 cells (Fig. 6B, third row), the Hsp70 signals were relatively
stronger when compared to that of control. Interestingly,
homogeneous AIF signals were only found in the cytosol but
not in the cell nucleus. Also, Hsp70 appeared in the cytosol
only (Fig. 6B, third row). It seems therefore likely that AIF
was co-localized with Hsp70 in the cytosol at day 6 after
EPO treatment, but was localized rather ubiquitously in both
the control or STS treated TF-1 cells. This supports our spec-
ulation that Hsp70 limits the nuclear accumulation of AIF by
binding and sequestering it in the cytosol.
Next, the interaction between AIF and Hsp70 was further
verify by co-immunoprecipitation. In this experiment, rabbit
polyclonal antibody against human AIF was added to cell ly-
sates and the immune complexes were precipitated with pro-
tein A–Sepharose. Proteins attached to the immunosorbent
were then analyzed with Western blot using anti-Hsp70 anti-
body and mouse anti-human AIF monoclonal antibody. As
shown in Fig. 6C, anti-AIF polyclonal antibody was able to
precipitate AIF from untreated, 6 day-EPO- and STS-treated
groups. However, Hsp70 was only co-immunoprecipitated
with AIF in the EPO-treated cells. Collectively, these ﬁndings
suggest that Hsp70 directly interacts with AIF and the absence
of AIF in cell nucleus was a protection through Hsp70 which
binds, retains AIF in the cytosol.n of TF-1 cells after EPO treatment. TF-1 cells (4 · 105 ml1) were
oncentrations as indicated for 24 h at 37 C, 5% CO2. After treatments,
eosomal (right panel) DNA fragmentation were determined by using
Fig. 6. Hsp70 was transiently expressed and inhibited the nuclear import of AIF in TF-1 cells after EPO treatment. TF-1 cells (4 · 105 ml1) were
cultured with EPO (1 U/ml) for diﬀerent days at 37 C, 5% CO2. Total cell lysates containing equal amount of proteins per lane were subject to
standard SDS–PAGE and Western analysis with antibodies for Hsp70 (70 kDa) and b-tubulin (55 kDa, as an internal control) (A). TF-1 cells after
treatments as indicated were ﬁxed, immunolabelled with anti-AIF and -Hsp70 antibodies, and observed under a confocal microscope. At the end of
experiments, cell nucleus was located by AO. Scale bar represents the cell size in 2 lm (B). TF-1 cells after treatments as shown were lysed and co-
immunoprecipitation was performed with protein A–Sepharose as described in Section 2. Proteins attached to the immunosorbent were analyzed by
using SDS–PAGE and Western blot analysis with anti-Hsp70 and -AIF antibody (C).
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with EPO and Hsp70 inhibitor
To further conﬁrm the anti-apoptotic role of Hsp70 during
erythroid development, a Hsp inhibitor KNK437 was em-
ployed in our study [17]. As shown in the Western blot analysis
(Fig. 7A), the Hsp70 expression in the control and EPO-trea-
ted group was blocked by KNK437 (100 lM) to a low level
when compared to their corresponding control without Hsp
inhibitor. At such concentration, KNK437 itself did not show
any toxic eﬀect in the control as revealed in the confocal sec-
tions in terms of cell and nuclear morphology, and the level
of Hsp70 was relatively low also (Fig. 7B, panels m–p). When
cells were treated with EPO for 6 days together with KNK437
for the last 24 h, the signal of Hsp70 was weak as well and the
AIF was found in the nuclear region (Fig. 7B, panels i–l).
Without KNK437, both the AIF and Hsp70 were found inthe cytosol of the EPO-treated cells (Fig. 7B, panels e–h).
Accordingly, the protective eﬀect of Hsp70 on blocking
DNA fragmentation was partially abolished by KNK437. As
indicated in Fig. 7C, DNA fragmentation was detected by TU-
NEL assay only in the group co-treated with EPO and
KNK437, while the control, KNK437- and EPO-treated
groups did not show any DNA fragmentation. Taken together,
our results suggest that Hsp70 retains and sequesters AIF in
the cytosol to prevent the cells from dying during erythropoi-
esis.4. Discussion
During erythropoiesis, activation of executioner caspases is
required for erythroid diﬀerentiation [18]. Based on the work
Fig. 7. Hsp70 inhibitor reduced Hsp70 expression and promoted DNA fragmentation in EPO-treated TF-1 cells. TF-1 cells (4 · 105 ml1) were
cultured with or without EPO (1 U/ml, for 6 days) in the absence or presence of Hsp70 inhibitor KNK437 (100 lM, for the last 24 h) as indicated at
37 C, 5% CO2. After treatments, total cell lysates containing equal amount of proteins per lane were subject to standard SDS–PAGE and Western
analysis with antibodies for Hsp70 (70 kDa), and b-tubulin (55 kDa, as an internal control for total lysates) (A). After treatments, TF-1 cells were
ﬁxed, immunolabelled with anti-AIF and -Hsp70 antibodies, and observed under a confocal microscope. At the end of experiments, cell nucleus was
located by AO. Scale bar represents the cell size in 2 lm (B). After treatments, DNA fragmentation was determined by TUNEL assays. Figure in
each panel represents the percentage of cells with DNA fragmentation in the M1 region (C).
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a mitochondria-dependent pathway similar to that identiﬁed in
apoptosis. Nevertheless, no mechanism was reported to ex-
plain why erythroid cells could survive with depolarized mito-
chondria.
In the present study, we demonstrated with the TF-1 model
that DWm depolarization is an important factor, at least in the
later stage of erythropoiesis (day 6 onwards in our case), gov-
erning erythroid development (Figs. 1–3). Similar to what have
been seen in apoptosis, cytochrome c and AIF were released
into the cytosol (Fig. 4). Conceivably, cytochrome c initiates
apoptosome formation and the subsequent activation of cas-
pase-9 and -3 cascade. Results from our previous study con-
ﬁrmed that although ICAD was cleaved by caspase-3, no cell
death was observed during erythroid development. Our major
ﬁnding is that CAD is downregulated at both the mRNA and
protein level. This explains why erythroid cells escape from cell
death with activated caspase-3 during erythropoiesis [7].
On the other hand, AIF is another mitochondrial protein re-
leased into the cytosol during erythroid development (Fig. 4).
AIF carries a unique capacity to induce caspase- independent
large-scale (50 kbp) DNA fragmentation [10]. Despite DWm
depolarization and release of AIF were found in TF-1 cells
after EPO treatment, no large scale and internucleosomal
DNA fragmentation was detected by agarose electrophoresis
(Fig. 5) and TUNEL assay (Fig. 7C). To allow TF-1 cells to
survive with AIF release after stimulation with EPO, there
must be some protective mechanisms to neutralize the AIF
activity to avoid DNA fragmentations. In fact, the whole nu-
clei but not blebs with DNA fragments are expelled from ery-
throblasts and engulfed by the macrophages late in
erythropoiesis [19].
Under normal conditions, Hsp70 interacts with nascent
polypeptides to facilitate proper folding [11]. When overex-
pressed, Hsp70 increases the tumorigenicity of cancer cells in
animal model [20]. When downregulated, Hsp70 is suﬃcient
to kill tumor cells [21]. Mechanistically, Hsp70 has been re-
ported to block apoptosis by reducing leakage of AIF from
mitochondria and by retaining AIF in the cytosol [15]. Pre-
venting the translocation of AIF into cell nucleus is regarded
as the major mechanism that Hsp70 inhibits apoptosis. When
AIF decoy ADD70 was transfected and expressed in human
cancer cells, neutralization of Hsp70 sensitized the cancer cells
to apoptosis induced by a variety of death stimuli [22]. For
these reasons, we examined the possible interaction of AIF
and Hsp70 and their eﬀects on DNA damages in TF-1 cells
with EPO treatment.
Interestingly, Hsp70 was found to be transiently upregulated
at day 6 after EPO administration (Fig. 6A). More impor-
tantly, our results from co-immunoprecipitation (Fig. 6C)
and confocal microscopy (Figs. 6B, 7B) showed that Hsp70
interacted with AIF and retained it in the cytosol during diﬀer-
entiation. When the Hsp70 expression was blocked by the Hsp
inhibitor KNK437, DNA fragmentation was observed in the
EPO-treated cells. Therefore, our ﬁnding in the present study
is that Hsp70 inhibits the translocation of AIF to the nucleus,
retaining it within the cytosol, thereby keeping it away from its
nuclear target during erythropoiesis. This mechanism was only
demonstrated previously in tumor cells to evade apoptosis [23].
Now, we extend this interesting mechanism to erythropoiesis.
In zebraﬁsh, Hsp70 is also expressed during a distinct tem-
poral window at normal growth temperatures for lens forma-tion [24], a system similar to erythropoiesis with caspase-3
activation and nuclei extrusion [25]. When Hsp70 antisense oli-
gonucleotides were used, embryos with injections exhibited a
small and underdeveloped lens phenotype [24]. Also, it was
found in zebraﬁsh that a single point mutation in Hspa9b, a
member of the Hsp70 family, led to a developmental blood de-
fect including anemia and blood cell apoptosis [26]. These
observations therefore support our ﬁndings that Hsp70 plays
a crucial role in cell diﬀerentiation.
In conclusion, our ﬁndings suggest that DWm depolarization
is important for erythroid diﬀerentiation and the release of
AIF was retained in the cytosol by Hsp70 to avoid caspase-
independent DNA fragmentation.References
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